Roche's laboratory test for 14 high-risk HPV types, approved by the FDA for primary cervical screening and, since 2024, for samples women take themselves in a clinic.
The cobas HPV Test (Roche Molecular Systems) was approved by the FDA on 19 April 2011 (PMA P100020) to detect 14 high-risk HPV types, identifying types 16 and 18 while concurrently detecting the rest (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68). The version for the cobas 6800/8800 Systems followed on 3 April 2020 (PMA P190028), indicated for routine cervical cancer screening "including triage of ASC-US cytology, co-testing (or adjunctive screen) with cytology, and HPV primary screening of women to assess the risk for cervical precancer and cancer"; a supplement of 19 September 2025 extends it to the cobas 5800 System. On 14 May 2024 the FDA approved testing of self-collected vaginal specimens, obtained in a health-care setting, as an alternative when cervical sampling is contraindicated or cannot be obtained (supplements P100020/S055 and P190028/S009).
PCR amplification and hybridisation detect DNA of 14 high-risk HPV types in one run, naming HPV 16 and HPV 18 separately and the other 12 types as a group.
Self-collected vaginal specimens obtained in a health-care setting approved (P190028/S009, P100020/S055) source
| Region | Year | Indication |
|---|---|---|
| US | 2011 | Detection of 14 high-risk HPV types in cervical specimens (PMA P100020) |
| US | 2020 | cobas 6800/8800 version for routine cervical screening including primary HPV screening (PMA P190028) |
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"cobas HPV test" OR ABSTRACT:"cobas HPV test" OR TITLE:"Roche" OR ABSTRACT:"Roche" OR TITLE:"cobas HPV" OR ABSTRACT:"cobas HPV" OR TITLE:"cobas 4800 HPV Test" OR ABSTRACT:"cobas 4800 HPV Test" OR TITLE:"cobas HPV Test" OR ABSTRACT:"cobas HPV Test" OR TITLE:"cobas HPV for use on the cobas 5800/6800/8800 Systems" OR ABSTRACT:"cobas HPV for use on the cobas 5800/6800/8800 Systems") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about cobas HPV test (Roche), not a curated reading list.
Shares Aptima HPV Assay and Aptima HPV 16 18/45 Genotype Assay, CINtec PLUS Cytology (p16/Ki-67 dual stain), FDA medical device databases (PMA, 510(k), De Novo), Cervical precancer (CIN, HSIL/LSIL) and the tags test, screening-test.
Shares BD Onclarity HPV Assay (extended genotyping), FDA medical device databases (PMA, 510(k), De Novo), Cervical precancer (CIN, HSIL/LSIL), HPV DNA testing and self-sampling and the tags test, screening-test.
Shares FDA medical device databases (PMA, 510(k), De Novo), Cervical precancer (CIN, HSIL/LSIL), HPV DNA testing and self-sampling, Screening and the tags test, screening-test.
Shares FDA medical device databases (PMA, 510(k), De Novo), HPV DNA testing and self-sampling, Screening, Cervical cancer and the tags test, screening-test.
Shares FDA medical device databases (PMA, 510(k), De Novo), Screening and the tags test, screening-test.
Shares FDA medical device databases (PMA, 510(k), De Novo), Screening and the tags test, screening-test.
Shares FDA medical device databases (PMA, 510(k), De Novo), Screening and the tags test, screening-test.
Shares FDA medical device databases (PMA, 510(k), De Novo), Screening and the tags test, screening-test.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/